Showing results (1261-1270 of 1,588) with videos related to
Sort By:
Pageof 159
JAMA Dermatology|September 13, 2023
Skin-Related Quality of Life During Autoimmune Bullous Disease CourseZachary H Hopkins, Amber Jimenez, Vanina L Taliercio, et al.JAMA Dermatology|September 6, 2023
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-AnalysisYaxin Du, Wenjie Wu, Mei Chen, et al.JAMA Dermatology|August 9, 2023
Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With NemolizumabJunwen Deng, Viviane Liao, Varsha Parthasarathy, et al.JAMA Dermatology|August 9, 2023
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and OntarioJulian Matthewman, Mina Tadrous, Kathryn E Mansfield, et al.JAMA Dermatology|August 16, 2023
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma SyndromeMichael R Sargen, Jung Kim, Thomas P Potjer, et al.JAMA Dermatology|August 23, 2023
Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary AnalysisJoseph F Merola, Daniel C Butler, Thomas Mark, et al.JAMA Dermatology|October 25, 2023
Patient Perspectives on Social Risk Screening and Documentation in a Dermatology ClinicKamina Wilkerson, Emilia De Marchis, Nora Rudd, et al.JAMA Dermatology|July 5, 2023
Trends Over Time in Medicare for Advanced Practice Clinicians in Dermatology, 2013-2020Cassandra Mohr, Yao Li, Candice L Hinkston, et al.JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.JAMA Dermatology|November 7, 2019
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical TrialEric L Simpson, Amy S Paller, Elaine C Siegfried, et al.Pageof 159